Clavicular Width & Frame Looksmaxxing: What the Research Says About Peptides

If you've spent any time in the looksmaxxing space — watching channels like Clavicular, Hamza Ahmed, or Alex Eubank, or scrolling looksmaxxing forums — you already know that clavicular width is considered one of the highest-leverage physical attributes in male appearance optimization.

Wide clavicles create the visual foundation for broad shoulders, an athletic silhouette, and the coveted "V-taper" that almost every looksmaxxer is chasing. The question the research community keeps asking: can peptides influence clavicular development, bone width, and skeletal frame after growth plates close?

This guide breaks down what the scientific literature actually says.

Why Clavicular Width Matters in Looksmaxxing

The clavicle is the most laterally positioned bone in the shoulder girdle. Its length and angulation directly determine shoulder breadth — independent of muscle mass. A person with naturally wide clavicles will always appear broader than someone with narrow clavicles, even at identical levels of muscle development.

In attraction research and physical appearance studies, shoulder-to-waist ratio (SWR) is one of the most consistently identified predictors of perceived male attractiveness. The clavicle is the primary structural determinant of the "shoulder" half of this equation.

Creators like Clavicular on YouTube have built entire channels around this concept — documenting their own frame development journeys and analyzing the skeletal foundations of attractive physiques. Their core premise aligns with the published research: frame is foundational, and optimizing it is a legitimate looksmaxxing priority.

What Controls Clavicular Width?

Clavicular width is primarily determined by:

1. Genetics and growth hormone during puberty — the growth plates at the sternal and acromial ends of the clavicle fuse in late adolescence (typically ages 21–25 in males, later than most other bones)
2. IGF-1 levels during development — insulin-like growth factor 1 is the primary mediator of bone lengthening and widening
3. Mechanical loading — exercises placing lateral tension on the shoulder girdle may stimulate periosteal remodeling over time
4. Post-pubertal bone remodeling — even after growth plate fusion, bones continuously remodel in response to hormonal signals

The critical insight: the clavicle is one of the last bones to fully fuse. If you're in your late teens or early twenties, the window for clavicular growth may still be open. Even post-fusion, bone density, cortical thickness, and periosteal remodeling remain responsive to hormonal signals.

Growth Hormone Peptides and Skeletal Development

Growth hormone (GH) and its downstream mediator IGF-1 are the primary hormonal drivers of skeletal growth and bone remodeling. Age-related GH decline is one reason bone density and structural integrity decrease with aging. GH-releasing peptides aim to restore more youthful GH pulsatility.

CJC-1295

CJC-1295 is a modified GHRH analog that increases GH pulse amplitude from the pituitary.

Bone-relevant mechanisms:

• Elevates IGF-1, the primary mediator of bone cell (osteoblast) proliferation and activity
• Increases bone mineral density in studies of GH-deficient populations
• Improves collagen synthesis in periosteal tissue — the connective tissue covering bones that mediates remodeling
• In long-term GH optimization studies, improvements in bone geometry and cortical thickness have been observed

Looksmaxxing relevance: For users still within the clavicular growth window (under ~25), CJC-1295 may meaningfully amplify the natural GH signal driving clavicular development. Post-fusion, the benefit shifts toward bone density and structural integrity.

View CJC-1295 →

Ipamorelin

Ipamorelin is a selective GH secretagogue that triggers clean GH pulses without the cortisol or prolactin elevations seen with older-generation GH peptides like GHRP-2 or GHRP-6.

Bone-relevant mechanisms:

• Ghrelin receptor agonism drives GH release in a manner that closely mimics natural pulsatility
• IGF-1 elevation from consistent ipamorelin use correlates with measurable osteoblast activity in animal models
• Sleep quality improvement — GH release occurs predominantly during slow-wave sleep; improved sleep architecture amplifies the anabolic skeletal effects

The CJC-1295 + Ipamorelin combination is the most studied GH peptide stack and the gold standard in the looksmaxxing research community for systemic GH optimization.

View Ipamorelin →

MK-677 (Ibutamoren)

MK-677 is an orally active GH secretagogue and ghrelin receptor agonist. Unlike injectable peptides, it is taken orally once daily, making it a common entry point for looksmaxxers exploring GH optimization.

Bone-relevant mechanisms:

• Human clinical trial data (Nuttall et al., 2000) demonstrated significant increases in bone mineral density in healthy young adults after 12 months of MK-677
• Consistent, sustained IGF-1 elevation — MK-677 raises IGF-1 by 40–90% in published human studies
• Periosteal stimulation effects observed in longer-term animal models
• In elderly subjects, MK-677 maintained bone density that would otherwise decline

Looksmaxxing community context: Creators like Hamza Ahmed have discussed oral GH secretagogues as part of their optimization protocols. MK-677's oral route and extensive human data make it among the more accessible starting points for frame-focused looksmaxxers.

View MK-677 →

Sermorelin

Sermorelin is the earliest GHRH analog with the longest clinical track record — a 29-amino-acid sequence matching the biologically active portion of endogenous GHRH. It has been used in clinical medicine for decades, including in pediatric growth hormone deficiency protocols.

Bone-relevant mechanisms:

• Preserves pituitary GH secretory capacity — important for younger users who want to stimulate rather than replace natural GH production
• The most conservative and clinically established GH peptide for users concerned with long-term pituitary health
• Long-term sermorelin studies in adults show measurable improvements in bone density and lean mass

View Sermorelin →

BPC-157 and Connective Tissue Around the Shoulder Girdle

Clavicular frame looksmaxxing isn't purely about bone width — the shoulder girdle's appearance and function depend equally on the connective tissue (tendons, ligaments, cartilage) that attaches and supports the clavicle.

BPC-157 is a synthetic 15-amino-acid peptide with one of the largest published bodies of animal research on tendon and ligament repair.

Connective tissue mechanisms relevant to frame looksmaxxing:

• Accelerates tendon healing and structural reorganization
• Upregulates growth hormone receptors, making it synergistic with GH peptide stacks
• Anti-inflammatory effects allow harder training stimulus on the shoulder girdle without accumulating joint damage
• Published studies show accelerated collagen fiber organization in repaired tendons — translating to stronger, thicker connective tissue

For looksmaxxers performing heavy overhead pressing, lateral raises, and loaded carries to stimulate shoulder girdle development, BPC-157 is commonly stacked to manage the training volume that aggressive frame building requires.

View BPC-157 →

The Frame Looksmaxxing Stack

For users focused on clavicular width and overall frame development, the most commonly studied protocol in the looksmaxxing research community:

| Compound | Dose | Route | Frequency | |----------|------|-------|-----------| | CJC-1295 | 100–200 mcg | SC | 3× per week | | Ipamorelin | 200–300 mcg | SC | Before sleep, daily | | MK-677 | 12.5–25 mg | Oral | Daily, at night | | BPC-157 | 250 mcg | SC | Daily (shoulder area) |

Mechanism synergy:

• CJC-1295 + Ipamorelin: Amplified GH pulse amplitude via dual GHRH + ghrelin receptor stimulation
• MK-677: Sustained daytime IGF-1 elevation that complements the nocturnal GH pulses from the injectable stack
• BPC-157: Connective tissue support and GH receptor upregulation, enhancing the frame-building stimulus

What Influencers Say vs What the Research Shows

Clavicular (YouTube) and similar creators correctly identify that GH and IGF-1 optimization is the most evidence-backed hormonal lever for skeletal development — particularly in users under 25. Their content consistently points toward maximizing GH during the clavicular growth window.

Hamza Ahmed has spoken about GH peptides in the context of his overall optimization stack, focusing on the body composition and sleep quality benefits as much as direct skeletal effects.

Alex Eubank has discussed training approaches — specifically lateral loading movements — that create the mechanical stimulus supporting periosteal remodeling. This mechanical component is often underemphasized in peptide-only discussions.

The research consensus aligns with the more measured influencer takes: peptides are amplifiers, not magic. GH optimization is most powerful when combined with appropriate mechanical loading (training), adequate dietary protein and micronutrients (especially calcium, vitamin D3/K2), and sufficient sleep. The peptide stack potentiates the signal; the training and nutrition provide the direction.

The Growth Window Question

The most common question in frame looksmaxxing circles: am I past the window?

Clavicular growth plates typically fuse by ages 22–26 in males (the acromial end fuses last, often around age 25). After fusion, length increases stop — but bone remodeling, density, and connective tissue development continue indefinitely.

| Age Range | Primary Benefit from GH Optimization | |-----------|--------------------------------------| | 16–22 | May contribute to clavicular elongation; significant GH amplification of natural growth window | | 22–26 | Transition period; periosteal remodeling and density increase remain highly responsive | | 26+ | Bone density, connective tissue thickness, and hormonal milieu optimization; direct length increase unlikely |

Even post-fusion, the visual and structural benefits of optimized GH levels remain significant — through effects on bone density, muscle architecture, and connective tissue quality.

Research Disclaimer

All information in this guide is for educational purposes only. The compounds discussed are not FDA-approved for human use outside of specific clinical contexts. Nothing here constitutes medical advice. Always consult a qualified healthcare provider before beginning any protocol.

Browse GH Optimization Peptides →